|
DEPDC1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
2.162300E-02 |
| Normal-vs-Stage3 |
4.72860000044761E-07 |
| Normal-vs-Stage4 |
1.49500000157232E-08 |
| Stage1-vs-Stage2 |
9.086000E-01 |
| Stage1-vs-Stage3 |
1.479960E-01 |
| Stage1-vs-Stage4 |
9.116100E-02 |
| Stage2-vs-Stage3 |
4.643000E-01 |
| Stage2-vs-Stage4 |
4.771600E-01 |
| Stage3-vs-Stage4 |
9.673000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.824740E-03 |
| Normal-vs-Asian |
5.775900E-03 |
| Caucasian-vs-AfricanAmerican |
3.856300E-02 |
| Caucasian-vs-Asian |
9.807200E-01 |
| AfricanAmerican-vs-Asian |
2.965400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.46329615091645E-11 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
3.336200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.29896093881143E-14 |
| Normal-vs-Age(41-60Yrs) |
2.4743995741261E-10 |
| Normal-vs-Age(61-80Yrs) |
1.07250000003223E-06 |
| Normal-vs-Age(81-100Yrs) |
2.244000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.590000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.944400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.285600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.311000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.882600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.001600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.383300E-03 |
| Classical-VS-Follicular |
2.458800E-01 |
| Classical-VS-Other |
9.013000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
4.839000E-03 |
| Tall-VS-Other |
1.216650E-01 |
| Tall-VS-Normal |
3.96339960850867E-10 |
| Follicular-VS-Other |
5.938200E-01 |
| Follicular-VS-Normal |
3.373700E-02 |
| Other-VS-Normal |
7.512300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08390000308489E-08 |
| Normal-vs-N1 |
1.605899999646E-07 |
| N0-vs-N1 |
1.618990E-01 |
|
|
